Dixon Hubard Feinour & Brown Inc Viatris Inc Transaction History
Dixon Hubard Feinour & Brown Inc
- $842 Million
- Q2 2022
Shares
2 transactions
Others Institutions Holding VTRS
# of Institutions
1,100Shares Held
969MCall Options Held
2.63MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA140MShares$1.62 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.07 Billion0.02% of portfolio
-
State Street Corp Boston, MA62.1MShares$717 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$665 Million3.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD56.8MShares$656 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $14B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...